CHESTER MILTENBERGER: Open Payments
NPI 1902855505 · LAKE MARY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,804 in 106 payments from 19 companies in 2025. Trend: 2023 $2,107 · 2024 $1,823 · 2025 $1,804
Food & beverage: $1,804
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 16 | $368 |
| ABBVIE INC. | 12 | $191 |
| AstraZeneca Pharmaceuticals LP | 10 | $184 |
| HARMONY BIOSCIENCES LLC | 9 | $165 |
| Amgen Inc. | 18 | $160 |
| Lundbeck LLC | 7 | $156 |
| PFIZER INC. | 14 | $156 |
| Novo Nordisk Inc | 6 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
Products named: Auvelity, WAKIX, REXULTI, AIRSUPRA, OTEZLA, Rybelsus, Sunosi, QULIPTA.
Industry payments across FL — which companies pay providers there.
